EYEZIRGAN

LABORATOIRES THEA🇨🇦 Health Canada

Approval Id: 2d80d9330b10513e
Drug Approval Canada Name: EYEZIRGAN
Product Name: EYEZIRGAN
Status: Marketed
Status Date: 2023-09-26
Original Market Date: 2023-09-26
Din: 02530546
Drug Class: Human
Dosage Form: Gel
Route Of Administration: Ophthalmic
Schedule: Prescription
Ahfs: 52:04.20
Atc Original: S01AD09 GANCICLOVIR
Atc Name: s 01 ad 09
Aig Number: 0128037004
Company Name: LABORATOIRES THEA
Company Address: 12 Rue Louis Bleriot, Clermont-Ferrand, Cedex 2, France, 63017
Company Detail Path: /organization/laboratoires-thea

GANCICLOVIR

0.15 % / W/W

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

2d80d9330b10513e

Type

Standard